The dynamic range of circulating tumor DNA in metastatic breast cancer - Wikidata - wikimedia - TriplyDB

The dynamic range of circulating tumor DNA in metastatic breast cancer

The dynamic range of circulating tumor DNA in metastatic breast cancer

http://www.wikidata.org/entity/Q35000808

about

Evaluation and consequences of heterogeneity in the circulating tumor cell compartment Circulating tumor cells in breast cancer Circulating DNA as biomarker in breast cancer Mate-Pair Sequencing as a Powerful Clinical Tool for the Characterization of Cancers with a DNA Viral Etiology Metastatic triple-negative breast cancer patient with TP53 tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events.Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy Assessment of circulating copy number variant detection for cancer screening.Emerging concepts in liquid biopsies Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients.Methods: for studying pharmacogenetic profiles of combination chemotherapeutic drugs.The biology of circulating tumor cells.Role of Circulating Cell-Free DNA in Cancers.Cell-free circulating tumour DNA as a liquid biopsy in breast cancer.Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies Circulating tumor cells: clinical validity and utility.Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR Methodology.Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.Characterization of the release and biological significance of cell-free DNA from breast cancer cell lines Liquid biopsies for surveillance and monitoring treatment response of bladder cancer.Inferring expressed genes by whole-genome sequencing of plasma DNA.Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker.Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.Patient monitoring through liquid biopsies using circulating tumor DNA.The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer.Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer.Analysis of circulating tumor DNA in breast cancer as a diagnostic and prognostic biomarker.mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA.The potential of liquid biopsies for the early detection of cancer.Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma.Circulating tumor DNA (ctDNA) in the era of personalized cancer therapy Neueste technologische Entwicklungen für die Analyse von zirkulierender Tumor-DNA

P2860

Q26765357-FC5D2CAF-9CEA-4583-867B-77134A6FFBC6 Q26774808-97067798-B4D6-4031-9FFD-A38DCCDCB7CE Q26785343-315A22AE-C893-4BED-A2FB-B95C80B53037 Q26799320-CBA38FCA-AAA2-4374-86D9-5F933BCC1CFD Q33865098-6B19D3DE-49EC-40EA-AD90-2E792E649207 Q33866887-88FC4800-4EE6-4035-A2F3-5742CFBBCDAF Q33884196-2FE3855C-F5F3-451C-A4C6-CE57445D8EAF Q36337259-F7707316-ACCE-47BC-98A1-436A24963775 Q37639092-1FE5B328-9B8A-4E96-895F-E6D9E50CE832 Q37641638-F92ADC46-32EE-4C5D-B453-27B9FDB78B7C Q37662351-42A342A1-A312-4F67-A7BD-9AE3D215C437 Q38389809-E35F80EA-FABD-4588-885F-524A130C7F37 Q38513661-2802AA90-370D-4544-B65F-EEE1B2BC34AB Q38518846-2A458CCB-AFE1-4230-89C2-AF035D98FD8E Q38591963-F492A8E7-6F76-4656-A3BB-202761B4AEDF Q38699764-08ED9614-C2AA-4117-B420-A58E8D9FB741 Q38700222-3A4AC037-1506-4B9E-AE27-916727DEA212 Q39151285-86DA18F6-FC6C-46DD-8E8A-795919E13C64 Q41821680-78AC2D3F-9C9B-4FCD-A000-FB879E281BB8 Q41868457-4AB2C016-487C-44F7-ADDC-2DE2EE1CBBEF Q42335724-6AD26931-0787-438A-B993-0B35A689D438 Q42380808-E947E738-F56A-4AFB-BD01-14D128CBCA29 Q42774378-BEFDA54E-14F7-4A6F-87FC-6C7326228839 Q46670174-F4C8C325-BC83-481A-BC90-ADF76B2225CB Q47150180-A037654E-DFAD-4A4C-A574-56C620F5D7E1 Q47214510-B61A1758-7FAF-45B4-9743-C3797C8DDE03 Q48194423-AE0BD9B2-4729-40CD-BF21-C3140A539063 Q49220712-16A8A13A-2BB0-4D62-8B08-71BD802F5451 Q49740946-8D544407-3188-4F43-990B-D3A2615CFC90 Q52724596-2A77D79B-556C-4687-9E5C-FAD5E4BCB50E Q52843159-F4A2F048-79D0-4A7C-B66C-5D3708F1BE4C Q55269325-1F7D0A97-20C1-4583-AEBE-5001CE607BF1 Q55312090-BFEDB8A2-6BCD-4391-B8E1-700960172007 Q57147396-423F3D38-B633-48E4-8751-1CFA3759B831 Q57636579-D972AEC6-3A5A-429F-95E8-40730FFF2D12

P2860

The dynamic range of circulating tumor DNA in metastatic breast cancer

http://www.wikidata.org/entity/Q35000808

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The dynamic range of circulating tumor DNA in metastatic breast cancer

@ast

The dynamic range of circulating tumor DNA in metastatic breast cancer

@en

type

label

The dynamic range of circulating tumor DNA in metastatic breast cancer

@ast

The dynamic range of circulating tumor DNA in metastatic breast cancer

@en

prefLabel

The dynamic range of circulating tumor DNA in metastatic breast cancer

@ast

The dynamic range of circulating tumor DNA in metastatic breast cancer

@en

P1433

Q35000808-87496A86-83E5-4CF4-9F96-A4900EE51A83

P1476

Q35000808-2D9BA264-76FB-4464-BDC3-788597B3392E

P2093

Q35000808-0E230185-79C0-4857-BD5D-8B57EAE63EE3

Q35000808-1500D7A0-89F3-4CA8-A805-CB2A9B188908

Q35000808-5BA1EB40-A261-43AA-9528-F2EC59091C2D

Q35000808-69E1F1D1-67A5-4C41-B939-BF0EE71264C8

Q35000808-6BA60150-8FA5-49F2-AC65-EF8CDA0C8F88

Q35000808-84962BCC-415D-41C5-9D58-4E575CCE7F2E

Q35000808-9EE1E8DB-0511-48F6-BA18-07603CA3D98E

Q35000808-A9A00136-2C70-47C9-AE51-C1474D85458C

Q35000808-B761677A-7033-4B64-A825-9FD048E8FC7A

Q35000808-EF53B7B8-4F8D-44A7-851D-0CFE148D858C

P2860

Q35000808-0C7ECA13-7F20-439E-8C8D-922F11712FC9

Q35000808-2436ABF1-0839-4221-A0A5-65098C7734F3

Q35000808-31C00034-E0A1-465C-855E-AF49395A776A

Q35000808-3598D6C2-3CFD-415A-B2E3-94E02AE314C5

Q35000808-3974D313-9DC9-41F8-A15B-04387C9D9952

Q35000808-3B1CA03A-2B13-4B71-88B8-A3A0ADE92CB5

Q35000808-483D8A28-6AB6-483C-B935-B905F0EBEA31

Q35000808-4BA27EDF-9ADC-4307-8A6F-D9F77D4F320A

Q35000808-513287BB-A36C-49D2-A1FB-127F67F28CCD

Q35000808-653872BA-DE0F-4738-974F-847C15482157

P2888

Q35000808-CDD3D224-394B-42AA-ACF2-5A49416E5E8D

P304

Q35000808-F20E9B68-E6ED-427B-A480-4044B389B02F

P31

Q35000808-5BD2B73B-9961-4F3C-B580-7AD431B3E6CA

P356

Q35000808-2492AF57-7731-43A5-B5CF-80716C46BE82

P433

Q35000808-FC2C955A-1FA1-4283-8795-207A739951BA

P478

Q35000808-DF577127-DC2B-4804-BF4C-FA534B45F355

P50

Q35000808-3DECC241-CE99-4906-8EDC-0D7E78364C65

Q35000808-599D4329-83E0-44CE-B8B2-E672EF0A0B89

Q35000808-995E774E-9398-4EA9-9EE5-CFD9DADE8CA8

P577

Q35000808-297A518F-892C-4469-A81C-8826C9F7EE20

P5875

Q35000808-5EFD9F91-C87F-457E-9499-7B318065C3CC

P6179

Q35000808-9544469A-B5C8-4E44-BA4E-3A82062BD6B8

P698

Q35000808-A69C1D2D-9D74-4478-B2FF-6C3784C86CF2

P932

Q35000808-3E2262BC-34C9-4700-97CC-C6B80625FFC7

P356

S13058-014-0421-Y

P1433

Breast Cancer Research

P1476

The dynamic range of circulating tumor DNA in metastatic breast cancer

@en

P2093

Christin Gasch

http://www.w3.org/2001/XMLSchema#string

Edgar Petru

http://www.w3.org/2001/XMLSchema#string

Gunda Pristauz

http://www.w3.org/2001/XMLSchema#string

Ingrid Lafer

http://www.w3.org/2001/XMLSchema#string

Jochen B Geigl

http://www.w3.org/2001/XMLSchema#string

Klaus Pantel

http://www.w3.org/2001/XMLSchema#string

Martina Auer

http://www.w3.org/2001/XMLSchema#string

Maryam Heidary

http://www.w3.org/2001/XMLSchema#string

Oliver Mauermann

http://www.w3.org/2001/XMLSchema#string

Sabine Riethdorf

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating tumor cells versus tumor-derived cell-free DNA: rivals or partners in cancer care in the era of single-cell analysis?

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

Fast and accurate short read alignment with Burrows-Wheeler transform

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

Development of personalized tumor biomarkers using massively parallel sequencing

Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing

Circulating mutant DNA to assess tumor dynamics

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

Analysis of circulating tumor DNA to monitor metastatic breast cancer

P2888

s13058-014-0421-y

P304

421

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13058-014-0421-Y

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Michael R. Speicher

P577

2014-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264643675

http://www.w3.org/2001/XMLSchema#string

P6179

1022002351

http://www.w3.org/2001/XMLSchema#string

P698

25107527

http://www.w3.org/2001/XMLSchema#string

P932

4303230

http://www.w3.org/2001/XMLSchema#string